CN1348778A - Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy - Google Patents
Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy Download PDFInfo
- Publication number
- CN1348778A CN1348778A CN00130131A CN00130131A CN1348778A CN 1348778 A CN1348778 A CN 1348778A CN 00130131 A CN00130131 A CN 00130131A CN 00130131 A CN00130131 A CN 00130131A CN 1348778 A CN1348778 A CN 1348778A
- Authority
- CN
- China
- Prior art keywords
- cancer
- tuberculosis
- hepatitis
- parts
- aids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000030507 AIDS Diseases 0.000 title claims abstract description 23
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 13
- 201000011510 cancer Diseases 0.000 title claims abstract description 13
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 11
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 11
- 206010012601 diabetes mellitus Diseases 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 206010059245 Angiopathy Diseases 0.000 title abstract description 7
- 201000008827 tuberculosis Diseases 0.000 claims abstract description 10
- 201000008383 nephritis Diseases 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 10
- 208000011580 syndromic disease Diseases 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 9
- 241001161070 Calomela Species 0.000 claims description 9
- 241000218176 Corydalis Species 0.000 claims description 9
- 239000004863 Frankincense Substances 0.000 claims description 9
- 241000124079 Mylabris Species 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 9
- 241000131808 Scolopendra Species 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000004576 sand Substances 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 claims 10
- 208000024172 Cardiovascular disease Diseases 0.000 claims 5
- 208000026106 cerebrovascular disease Diseases 0.000 claims 5
- 230000002526 effect on cardiovascular system Effects 0.000 claims 5
- 208000001297 phlebitis Diseases 0.000 claims 5
- 206010047115 Vasculitis Diseases 0.000 claims 3
- 241000219138 Luffa Species 0.000 claims 1
- 235000003956 Luffa Nutrition 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 241000725303 Human immunodeficiency virus Species 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000035473 Communicable disease Diseases 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 208000037157 Azotemia Diseases 0.000 abstract description 2
- 206010005003 Bladder cancer Diseases 0.000 abstract description 2
- 206010056377 Bone tuberculosis Diseases 0.000 abstract description 2
- 206010048768 Dermatosis Diseases 0.000 abstract description 2
- 206010019280 Heart failures Diseases 0.000 abstract description 2
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract description 2
- 208000032923 Lobar pneumonia Diseases 0.000 abstract description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 2
- 206010030113 Oedema Diseases 0.000 abstract description 2
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 abstract description 2
- 206010035664 Pneumonia Diseases 0.000 abstract description 2
- 206010040047 Sepsis Diseases 0.000 abstract description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 2
- 206010043376 Tetanus Diseases 0.000 abstract description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 abstract description 2
- 206010047642 Vitiligo Diseases 0.000 abstract description 2
- 206010003119 arrhythmia Diseases 0.000 abstract description 2
- 230000006793 arrhythmia Effects 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 210000000481 breast Anatomy 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 206010017758 gastric cancer Diseases 0.000 abstract description 2
- 208000005252 hepatitis A Diseases 0.000 abstract description 2
- 208000002672 hepatitis B Diseases 0.000 abstract description 2
- 230000036543 hypotension Effects 0.000 abstract description 2
- 208000026278 immune system disease Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 201000002313 intestinal cancer Diseases 0.000 abstract description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 abstract description 2
- 206010038534 renal tuberculosis Diseases 0.000 abstract description 2
- 208000013223 septicemia Diseases 0.000 abstract description 2
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 201000011549 stomach cancer Diseases 0.000 abstract description 2
- 208000009852 uremia Diseases 0.000 abstract description 2
- 201000005112 urinary bladder cancer Diseases 0.000 abstract description 2
- 206010047470 viral myocarditis Diseases 0.000 abstract description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract 1
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 206010020741 Hyperpyrexia Diseases 0.000 abstract 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract 1
- 208000008839 Kidney Neoplasms Diseases 0.000 abstract 1
- 208000001388 Opportunistic Infections Diseases 0.000 abstract 1
- 206010038389 Renal cancer Diseases 0.000 abstract 1
- 208000002495 Uterine Neoplasms Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 201000010982 kidney cancer Diseases 0.000 abstract 1
- 210000000244 kidney pelvis Anatomy 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 206010046766 uterine cancer Diseases 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis and angiopathy, in particular to a Chinese medicinal preparation for treating various diseases. Such as AIDS virus carrier, various opportunistic infections of AIDS, liver cancer, lung cancer, stomach cancer, uterine cancer, intestinal cancer, renal pelvis, kidney cancer, bladder cancer, etc., viral hepatitis, such as hepatitis A, hepatitis B, angiopathy, such as arteriosclerosis, cerebral thrombosis, coronary heart disease, myocardial infarction, angina pectoris, heart failure, arrhythmia, nephritis, uremia, puerperal wind, septicemia, tetanus, vitiligo, dermatosis, rheumatism, rheumatoid diseases, tuberculosis, such as pulmonary tuberculosis, bone tuberculosis, lymphoid tuberculosis, renal tuberculosis, breast tuberculosis, etc., immune diseases, infectious diseases, trauma, infectious diseases, cold, lobar pneumonia, unknown hyperpyrexia, edema, inflammation, viral myocarditis, hypotension, venereal disease, etc.
Description
The present invention relates to a kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS), cancer, hepatitis, diabetes, angiopathy.Specifically with the Chinese patent medicine of Chinese herbal medicine preparation.The invention still further relates to preparation method.
Acquired immune deficiency syndrome (AIDS), cancer, hepatitis, angiopathy are the world's present five big difficult diseases.Both at home and abroad to the treatment of five kinds of diseases, following several shortcoming is arranged at present:
The medicine that in the world treatment of acquired immune deficiency syndrome (AIDS) is not also had radical cure at present, can only suppress virus replication, reduce viral load, postpone morbidity, chemicotherapy and the cancer pain hardship is controlled in operation and side effect is big, diabetes are by taking medicine all the life, the biguanide drug side effect is big, with producing antibody, the medicine of treatment angiopathy still leaves sequela through taking for a long time to insulin for a long time.Now with some Chinese medicine preparation are arranged, but all can only prolong life by mitigate the disease.
The purpose of this invention is to provide and a kind ofly kill HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), reverse and swollenly to stay cell, kill hepatitis virus, endocrine regulation, the pure Chinese medicinal preparation of enhancing human body immunity function.
The preparation method that the purpose of this invention is to provide medicament in this.
Solution of the present invention is according to herbal nature in motherland's medical treasure-house and combination principle, selected blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, strengthening the body resistance, the germ-resistant natural Chinese medicinal herb of detoxification, adjust immunity of organism, enhance metabolism, detoxicating element, blood stasis dispelling blood play kills HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), the contagious effect of controller, the treatment cancer is to regulate human endocrine, and making tumour cell reversing is principle.Regulate metabolism disorder, promote islet secretion, realized the effect of medicine Zhiduo County disease.Can treat acquired immune deficiency syndrome (AIDS), cancer, hepatitis, diabetes.As hepatocarcinoma, pulmonary carcinoma, gastric cancer, uterus carcinoma, breast carcinoma, intestinal cancer, kidney
Cancer, bladder cancer, hepatitis A, hepatitis B, arteriosclerosis, coronary heart disease, angina pectoris, myocardium stalk, heart failure, arrhythmia, nephritis, uremia, puerperal exposure to wind, septicemia, tetanus, vitiligo, dermatosis, rheumatism, rheumatoid, pulmonary tuberculosis, bone tuberculosis, lymphoid tuberculosis, renal tuberculosis, tuberculosis of breast, immunological disease, infection disease, wound, infectious disease, flu, lobar pneumonia, nameless high fever, edema, inflammation, viral myocarditis, hypotension etc.
The present invention is made up of following component: (weight ratio)
Olibanum 10-15 Fen Zhu sand 10-12 part Herba Alii fistulosi 20-30 part
Myrrha 4-6 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 10-14 part
Scorpio 2-4 part Magnetitum 10-12 part Semen Armeniacae Amarum 10-14 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 40-60 part
Calomelas 4-6 part Borneolum Syntheticum 10-15 part
The formula optimization weight ratio scope of preparation medicine of the present invention is: (parts by weight)
Olibanum 8-10 Fen Zhu sand 8-10 part Herba Alii fistulosi 15-20 part
Myrrha 3-5 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 8-12 part
Scorpio 2-4 part Magnetitum 8-10 part Semen Armeniacae Amarum 8-12 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 30-50 part
Calomelas 3-5 part Borneolum Syntheticum 8-10 part
Optimum formula ratio of the present invention is: (parts by weight)
20 parts in 10 portions of Herba Alii fistulosis of Olibanum 10 Fen Zhu sand
12 parts of 8 parts of Fructus Luffae seeds of 5 parts of Rhizoma Corydalis of Myrrha
12 parts in 10 parts of Semen Armeniacae Amarums of 4 parts of Magnetitums of Scorpio
50 parts in 4 portions of Fructus Jujubaes of 4 portions of Mylabris of Scolopendra
10 parts of 5 parts of Borneolum Syntheticums of Calomelas
Above-mentioned each component is made medicine production method of the present invention:
1, gets Olibanum, Myrrha, Scorpio, Scolopendra, Calomelas, Zhu sand, Rhizoma Corydalis, Magnetitum, Mylabris, Borneolum Syntheticum, Fructus Luffae seed, Semen Armeniacae Amarum, pulverizing 120 order fineness earlier.
2, Herba Alii fistulosi, Fructus Jujubae are dried in the shade powder 120 order fineness.
3, will go up medicated powder and mix, measure and even bottling, sealing, every bottle of 10g with 1 times in 5 times of amounts of 60 degree hot water medicated powder.
Embodiment
One, take by weighing raw material by following proportioning:
20 kilograms in 10 kilograms of Herba Alii fistulosis of Olibanum 10 Qian Ke Zhu sand
12 kilograms of 8 kilograms of Fructus Luffae seeds of 5 kilograms of Rhizoma Corydalis of Myrrha
12 kilograms in 10 kilograms of Semen Armeniacae Amarums of 4 kilograms of Magnetitums of Scorpio
50 kilograms in 4 kilograms of Fructus Jujubaes of 4 kilograms of Mylabris of Scolopendra
10 kilograms of 5 kilograms of Borneolum Syntheticums of Calomelas
Claims (5)
1, a kind of treat acquired immune deficiency syndrome (AIDS), cancer, diabetes, vasculitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, medicine, its feature it be the medicament of making by the raw material of following weight ratio:
Olibanum 10-15 Fen Zhu sand 10-12 part Herba Alii fistulosi 20-30 part
Myrrha 4-6 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 10-14 part
Scorpio 2-4 part Magnetitum 10-12 part Semen Armeniacae Amarum 10-14 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 40-60 part
Calomelas 4-6 part Borneolum Syntheticum 10-15 part
2, according to the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, cancer, diabetes, vasculitis, phlebitis, hepatitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, medicine, wherein the weight proportion of each raw material is:
Olibanum 8-10 Fen Zhu sand 8-10 part Herba Alii fistulosi 15-20 part
Myrrha 3-5 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 8-12 part
Scorpio 2-4 part Magnetitum 8-10 part Semen Armeniacae Amarum 8-12 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 30-50 part
Calomelas 3-5 part Borneolum Syntheticum 8-10 part
3, according to the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, cancer, diabetes, hepatitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis wherein the best proportioning of each raw material weight be:
20 parts in 10 portions of Herba Alii fistulosis of Olibanum 10 Fen Zhu sand
12 parts of 8 parts of Semen Luffaes of 5 parts of Rhizoma Corydalis of Myrrha
12 parts in 10 parts of Semen Armeniacae Amarums of 4 parts of Magnetitums of Scorpio
50 parts in 4 portions of Fructus Jujubaes of 4 portions of Mylabris of Scolopendra
10 parts of 5 parts of Borneolum Syntheticums of Calomelas
4, according to claim 1,2 or 3 described treatment acquired immune deficiency syndrome (AIDS), cancer, diabetes, hepatitis, arteries and veins
The medicine of Guan Yan, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, it is characterized in that it is that a kind of special dosage form is heard agent on the pharmaceutics.
5, according to the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 4, cancer, diabetes, hepatitis, vasculitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis.It is characterized in that getting Olibanum, Myrrha, Scorpio, Scolopendra, Calomelas, Borneolum Syntheticum, Mylabris, Magnetitum powder, Rhizoma Corydalis, Zhu sand, Fructus Luffae seed, Semen Armeniacae Amarum, clean, dry, pulverize 120 order fineness, Fructus Jujubae, Herba Alii fistulosi, air-dry, powder 120 orders and mix after, with 60 degree hot water, 5 times in water, 1 times in medicated powder and the sealing of sparing, bottle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00130131A CN1348778A (en) | 2000-10-17 | 2000-10-17 | Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00130131A CN1348778A (en) | 2000-10-17 | 2000-10-17 | Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1348778A true CN1348778A (en) | 2002-05-15 |
Family
ID=4593986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00130131A Pending CN1348778A (en) | 2000-10-17 | 2000-10-17 | Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1348778A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006131054A1 (en) * | 2005-06-04 | 2006-12-14 | Zichun Li | Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery |
CN101549064B (en) * | 2005-10-08 | 2011-11-09 | 河北以岭医药研究院有限公司 | Medicament composition containing chilopod acting on NEI network and uses thereof |
CN103181945A (en) * | 2011-12-31 | 2013-07-03 | 江苏众红生物工程创药研究院有限公司 | Novel application of luffa seeds |
CN103191170A (en) * | 2012-01-08 | 2013-07-10 | 江苏众红生物工程创药研究院有限公司 | Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof |
-
2000
- 2000-10-17 CN CN00130131A patent/CN1348778A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006131054A1 (en) * | 2005-06-04 | 2006-12-14 | Zichun Li | Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery |
CN101549064B (en) * | 2005-10-08 | 2011-11-09 | 河北以岭医药研究院有限公司 | Medicament composition containing chilopod acting on NEI network and uses thereof |
CN103181945A (en) * | 2011-12-31 | 2013-07-03 | 江苏众红生物工程创药研究院有限公司 | Novel application of luffa seeds |
CN103181945B (en) * | 2011-12-31 | 2016-01-13 | 江苏众红生物工程创药研究院有限公司 | The purposes of Semen Luffae |
CN103191170A (en) * | 2012-01-08 | 2013-07-10 | 江苏众红生物工程创药研究院有限公司 | Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101791378B (en) | Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration | |
CN111097040A (en) | Antiviral lung-heat clearing peptide | |
CN1876053A (en) | A pharmaceutical used for moxibustion and preparation method thereof | |
CN1331502C (en) | Chinese medicine composition | |
CN1348778A (en) | Pure Chinese medicinal preparation for treating AIDS, cancer, hepatitis, diabetes and angiopathy | |
CN111658618A (en) | Pure traditional Chinese medicine navel paste pill and preparation method thereof | |
CN1208646A (en) | Medicine for treating gastrointestinal ulcer and gastritis | |
CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
CN1742958A (en) | Medicated pillow for treating cardiovascular and cerebrovascular disease | |
CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
CN104998137A (en) | Traditional Chinese medicine composite for treating lung diseases | |
CN1939498A (en) | Chinese-medicinal preparation for treating psoriasis | |
CN104873911B (en) | A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment | |
CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
CN1883679A (en) | Medicine for treating pulmonary tuberculosis | |
CN101032612A (en) | Medicine preparation for curing inflammation and tumour and its prepn process | |
CN112618626A (en) | Traditional Chinese medicine spray for treating herpes zoster and preparation method thereof | |
CN1074670C (en) | Medicine for the treatment of rheumatism and arthritis | |
CN112076269A (en) | Auxiliary medicine for treating cardiovascular diseases | |
CN100431573C (en) | Medicine for treating aurigo | |
CN1657082A (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS | |
CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
CN101658549A (en) | Oral medicine for treating psoriasis | |
CN1301724C (en) | Medicine for thrombotic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |